Patents by Inventor Bhaumik A. Pandya

Bhaumik A. Pandya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted xanthine derivatives
    Patent number: 9328113
    Abstract: This invention relates to novel compounds that are substituted xanthine derivatives and pharmaceutically acceptable salts thereof. For example, this invention relates to novel substituted xanthine derivatives that are derivatives of pentifylline. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions for which pentifylline and related compounds are beneficial.
    Type: Grant
    Filed: April 12, 2013
    Date of Patent: May 3, 2016
    Assignee: Concert Pharmaceuticals, Inc.
    Inventors: Roger D. Tung, Bhaumik Pandya, Scott L. Harbeson
  • Deuterated derivatives of ruxolitinib
    Patent number: 9249149
    Abstract: The present invention in one embodiment provides a compound of Formula A: or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising the compound; and methods of treating the indications disclosed herein.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: February 2, 2016
    Assignee: Concert Pharmaceuticals, Inc.
    Inventors: I. Robert Silverman, Julie F. Liu, Adam J. Morgan, Bhaumik Pandya, Scott L. Harbeson
  • Derivatives of Pyrazole-Substituted Amino-Heteroaryl Compounds
    Publication number: 20150366853
    Abstract: This invention relates to novel pyrazole-substituted amino-heteroaryl compounds of Formula I: and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an inhibitor of anaplastic lymphoma kinase (ALK).
    Type: Application
    Filed: August 31, 2015
    Publication date: December 24, 2015
    Applicant: CONCERT PHARMACEUTICALS, INC.
    Inventors: Bhaumik A. Pandya, Craig E. Masse, Ian Robert Silverman, Roger D. Tung
  • FLUORO-DERIVATIVES OF PYRAZOLE-SUBSTITUTED AMINO-HETEROARYL COMPOUNDS
    Publication number: 20150299170
    Abstract: This invention relates to novel fluoro-derivatives of pyrazole-substituted amino-heteroaryl compounds of Formula I: and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an inhibitor of anaplastic lymphoma kinase (ALK).
    Type: Application
    Filed: November 20, 2013
    Publication date: October 22, 2015
    Inventors: Bhaumik A. Pandya, Roger Tung
  • Deuterated Ponatinib
    Publication number: 20150291594
    Abstract: The present invention provides novel derivatives of ponatinib (AP-24534), a BCR-ABL kinase inhibitor with activity against the T3151 Gatekeeper mutant.
    Type: Application
    Filed: August 14, 2013
    Publication date: October 15, 2015
    Applicant: CONCERT PHARMACEUTICALS, INC.
    Inventor: Bhaumik A. Pandya
  • Derivatives of pyrazole-substituted amino-heteroaryl compounds
    Patent number: 9145390
    Abstract: This invention relates to novel pyrazole-substituted amino-heteroaryl compounds of Formula I: and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an inhibitor of anaplastic lymphoma kinase (ALK).
    Type: Grant
    Filed: September 3, 2013
    Date of Patent: September 29, 2015
    Assignee: Concert Pharmaceuticals, Inc.
    Inventors: Bhaumik Pandya, Craig E. Masse, Ian Robert Silverman, Roger Tung
  • Deuterated Derivatives of Ruxolitinib
    Publication number: 20150239896
    Abstract: The present invention in one embodiment provides a compound of Formula A: or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising the compound; and methods of treating the indications disclosed herein.
    Type: Application
    Filed: May 8, 2015
    Publication date: August 27, 2015
    Inventors: I. Robert Silverman, Julie F. Liu, Adam J. Morgan, Bhaumik Pandya, Scott L. Harbeson
  • DEUTERATED DERIVATIVES OF RUXOLITINIB
    Publication number: 20150197525
    Abstract: The present invention in one embodiment provides a compound of Formula A: or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising the compound; and methods of treating the indications disclosed herein.
    Type: Application
    Filed: December 15, 2014
    Publication date: July 16, 2015
    Inventors: I. Robert Silverman, Julie F. Liu, Adam J. Morgan, Bhaumik Pandya, Scott L. Harbeson
  • TETRAHYDRONAPHTHALENE DERIVATIVES
    Publication number: 20140155444
    Abstract: This invention relates to novel tetrahydronaphthalene derivatives, and pharmaceutically acceptable salts thereof according to the following formulae, in one embodiment: as described herein. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a selective T-type calcium channel blocker.
    Type: Application
    Filed: October 21, 2013
    Publication date: June 5, 2014
    Applicant: Concert Pharmaceuticals Inc.
    Inventors: Roger Tung, Craig E. Masse, Bhaumik A. Pandya
  • DERIVATIVES OF PYRAZOLE-SUBSTITUTED AMINO-HETEROARYL COMPOUNDS
    Publication number: 20140005211
    Abstract: This invention relates to novel pyrazole-substituted amino-heteroaryl compounds of Formula I: and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an inhibitor of anaplastic lymphoma kinase (ALK).
    Type: Application
    Filed: September 3, 2013
    Publication date: January 2, 2014
    Applicant: CONCERT PHARMACEUTICALS, INC.
    Inventors: Bhaumik Pandya, Craig E. Masse, Ian Robert Silverman, Roger Tung
  • TETRAHYDRONAPHTHALENE DERIVATIVES
    Publication number: 20120122944
    Abstract: This invention relates to novel tetrahydronaphthalene derivatives, and pharmaceutically acceptable salts thereof according to the following formulae, in one embodiment: as described herein. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a selective T-type calcium channel blocker.
    Type: Application
    Filed: September 7, 2011
    Publication date: May 17, 2012
    Applicant: CONCERT PHARMACEUTICALS INC.
    Inventors: Roger Tung, Craig E. Masse, Bhaumik A. Pandya